Vinva Investment Management
JAZZ icon

Vinva Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Vinva Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
3,869
-7,273
-65% -$1.59M 0.01% 320
2026
Q1 		$2.98M Buy
11,142
+7,043
+172% +$1.23M 0.04% 250
2025
Q4 		$1.04M Buy
+4,099
New +$628K 0.01% 302
2025
Q3 		– Sell
-2,928
Closed -$480K – 445
2025
Q2 		$480K Buy
2,928
+1,470
+101% +$160K 0.01% 356
2025
Q1 		$285K Sell
1,458
-1,439
-50% -$188K 0.01% 358
2024
Q4 		$573K Buy
2,897
+1,311
+83% +$155K 0.02% 341
2024
Q3 		$254K Buy
+1,586
New +$174K 0.01% 402
2024
Q2 		– Sell
-1,704
Closed -$205K – 435
2024
Q1 		$205K Hold
1,704
– – 0.01% 410
2023
Q4 		$210K Sell
1,704
-681
-29% -$85K 0.01% 388
2023
Q3 		$313K Buy
2,385
+440
+23% +$58.6K 0.03% 331
2023
Q2 		$241K Sell
1,945
-546
-22% -$73.5K 0.02% 358
2023
Q1 		$361K Buy
+2,491
New +$368K 0.03% 348

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vinva Investment Management's JAZZ Position: Q2 2026 in Review

Vinva Investment Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 65% in Q2 2026, selling an estimated $1.59M and leaving 3,869 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #320.

Vinva Investment Management first reported a position in JAZZ in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.98M in Q1 2026. 648 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Vinva Investment Management held 3,869 shares of Jazz Pharmaceuticals worth $1.34M as of Q2 2026.
  • Vinva Investment Management sold 7,273 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.59M.
  • Jazz Pharmaceuticals made up 0.01% of Vinva Investment Management's portfolio in Q2 2026, its #320 holding.
  • Vinva Investment Management first reported a position in Jazz Pharmaceuticals in Q1 2023 and has held it in 12 quarters since.
  • Vinva Investment Management's Jazz Pharmaceuticals position peaked at $2.98M in Q1 2026.
  • 648 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.